M. Pasanen
Oncology · 2011
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 10 citations into it
Whom M. Pasanen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from M. Pasanen's perspective
Ordered by how strongly the researchers M. Pasanen trusts endorse each paper. Same corpus, a different order for every researcher.
- The superfamily of organic anion transporting polypeptides. (Biochimica et Biophysica Acta)
- Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties (Pflügers Archiv)
- Drug interactions with lipid‐lowering drugs: Mechanisms and clinical relevance (Clinical pharmacology and therapy)
- Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. (Biochemical and Biophysical Research Communications - BBRC)
- Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. (Gastroenterology)
- A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. (American Journal of Physiology - Gastrointestinal and Liver Physiology)
- Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. (Gastroenterology)
- Membrane transporters in drug development (Nature reviews. Drug discovery)
- Cerivastatin and reports of fatal rhabdomyolysis. (New England Journal of Medicine)
- Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. (Journal of the American Medical Association (JAMA))